This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2018 Mar;15(3):135.

doi: 10.1038/nrclinonc.2018.15. Epub 2018 Jan 31.

Immunotherapy: Oncolytic viruses prime antitumour immunity

PMID: 29384144
DOI: 10.1038/nrclinonc.2018.15

Immunotherapy: Oncolytic viruses prime antitumour immunity

Diana Romero. Nat Rev Clin Oncol. 2018 Mar.

. 2018 Mar;15(3):135.

doi: 10.1038/nrclinonc.2018.15. Epub 2018 Jan 31.

Author

PMID: 29384144
DOI: 10.1038/nrclinonc.2018.15

No abstract available

PubMed Disclaimer

Similar articles

Harnessing the Power of Onco-Immunotherapy with Checkpoint Inhibitors.
Rajani KR, Vile RG. Rajani KR, et al. Viruses. 2015 Nov 13;7(11):5889-901. doi: 10.3390/v7112914. Viruses. 2015. PMID: 26580645 Free PMC article. Review.
Molecular Pathways: Mechanism of Action for Talimogene Laherparepvec, a New Oncolytic Virus Immunotherapy.
Kohlhapp FJ, Kaufman HL. Kohlhapp FJ, et al. Clin Cancer Res. 2016 Mar 1;22(5):1048-54. doi: 10.1158/1078-0432.CCR-15-2667. Epub 2015 Dec 30. Clin Cancer Res. 2016. PMID: 26719429 Review.
Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer.
Hamid O, Hoffner B, Gasal E, Hong J, Carvajal RD. Hamid O, et al. Cancer Immunol Immunother. 2017 Oct;66(10):1249-1264. doi: 10.1007/s00262-017-2025-8. Epub 2017 Jul 15. Cancer Immunol Immunother. 2017. PMID: 28712033 Free PMC article. Review.
Oncolytic Immunotherapy for Treatment of Cancer.
Tsun A, Miao XN, Wang CM, Yu DC. Tsun A, et al. Adv Exp Med Biol. 2016;909:241-83. doi: 10.1007/978-94-017-7555-7_5. Adv Exp Med Biol. 2016. PMID: 27240460 Review.
Oncolytic measles virus enhances antitumour responses of adoptive CD8⁺NKG2D⁺ cells in hepatocellular carcinoma treatment.
Chen A, Zhang Y, Meng G, Jiang D, Zhang H, Zheng M, Xia M, Jiang A, Wu J, Beltinger C, Wei J. Chen A, et al. Sci Rep. 2017 Jul 12;7(1):5170. doi: 10.1038/s41598-017-05500-z. Sci Rep. 2017. PMID: 28701757 Free PMC article.

See all similar articles

Cited by

Mesenchymal stem cell-released oncolytic virus: an innovative strategy for cancer treatment.
Ghasemi Darestani N, Gilmanova AI, Al-Gazally ME, Zekiy AO, Ansari MJ, Zabibah RS, Jawad MA, Al-Shalah SAJ, Rizaev JA, Alnassar YS, Mohammed NM, Mustafa YF, Darvishi M, Akhavan-Sigari R. Ghasemi Darestani N, et al. Cell Commun Signal. 2023 Feb 24;21(1):43. doi: 10.1186/s12964-022-01012-0. Cell Commun Signal. 2023. PMID: 36829187 Free PMC article. Review.
Immune Checkpoint Blockade Augments Changes Within Oncolytic Virus-induced Cancer MHC-I Peptidome, Creating Novel Antitumor CD8 T Cell Reactivities.
Kim Y, Konda P, Murphy JP, Paulo JA, Gygi SP, Gujar S. Kim Y, et al. Mol Cell Proteomics. 2022 Feb;21(2):100182. doi: 10.1016/j.mcpro.2021.100182. Epub 2021 Dec 16. Mol Cell Proteomics. 2022. PMID: 34922008 Free PMC article.
Mesenchymal stem cell carriers enhance anti-tumor efficacy of oncolytic virotherapy.
Wang X, Zhao X, He Z. Wang X, et al. Oncol Lett. 2021 Apr;21(4):238. doi: 10.3892/ol.2021.12499. Epub 2021 Jan 28. Oncol Lett. 2021. PMID: 33664802 Free PMC article. Review.
Supramolecularly engineered bacteria mediated calcium overload and immunotherapy of tumors.
Xie B, Dong L, Wang L, Wang R, Li C. Xie B, et al. Theranostics. 2024 Oct 7;14(17):6560-6570. doi: 10.7150/thno.99931. eCollection 2024. Theranostics. 2024. PMID: 39479452 Free PMC article.
Bacteria-triggered tumor-specific thrombosis to enable potent photothermal immunotherapy of cancer.
Yi X, Zhou H, Chao Y, Xiong S, Zhong J, Chai Z, Yang K, Liu Z. Yi X, et al. Sci Adv. 2020 Aug 14;6(33):eaba3546. doi: 10.1126/sciadv.aba3546. eCollection 2020 Aug. Sci Adv. 2020. PMID: 32851163 Free PMC article.

See all "Cited by" articles

References

1. Sci Transl Med. 2018 Jan 3;10 (422):null - PubMed
1. Sci Transl Med. 2018 Jan 3;10 (422):null - PubMed

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- scite Smart Citations